#StockInNews | Glenmark Pharmaceuticals gets US FDA approval for Progesterone Vaginal Inserts, 100 mg
β€1
#RupeeCheck | #Rupee opens at 92.66/$ vs Wednesdayβs close of 92.58/$
Market News ( Union Budget ) ( RBI Policy ) ( Market Quarterly Results )
#JustIn | #Honasa #Q4Updateπ πBusiness is expected to deliver growth in late twenties πMamaearth expected to deliver teens growth during the quarter
#StockInNews | Honasa Consumer Business Update: Expects Q4 FY26 growth in the late twenties percent range
β€1
#StockInNews | Anant Raj enters into supplementary agreement with Destination Properties
#NewsAlert | Russia offers US-sanctioned LNG to Asian buyers at 40% discount (Agencies)
#JustIn | Tata Power collaborates with #Databricks to build future-ready data & AI platform to accelerate energy transition
#JustIn | #CastrolIndia elevates its flagship products in 2 & 4-wheeler segments to full synthetic
#InsuranceData | March #General Insurance Data:
General Insurance data for March announced, #ICICILombard outperforms; premium growth at 21% vs 8% industry growth
General Insurance data for March announced, #ICICILombard outperforms; premium growth at 21% vs 8% industry growth
#StockInNews | Apollo Micro Systems completes blast trials for limpet mines
#StockInNews | Adani Green: Arm AGEL UAE signs JV agreement with Minerva Holding RSC
#JustIn | #EscortsKubota intends to launch a new tractor series by Powertrac soon
#GMBreweries reports #Q4Resultsπ
Net Profit down 11% at βΉ54 cr vs βΉ61 cr (YoY)
Revenue up 19.5% at βΉ202.2 cr vs βΉ169.2 cr (YoY)
EBITDA up 83% at βΉ53 cr vs βΉ29 cr (YoY)
Margin at 26% vs 17% (YoY)
Net Profit down 11% at βΉ54 cr vs βΉ61 cr (YoY)
Revenue up 19.5% at βΉ202.2 cr vs βΉ169.2 cr (YoY)
EBITDA up 83% at βΉ53 cr vs βΉ29 cr (YoY)
Margin at 26% vs 17% (YoY)
#AnandRathiWealth #Q4Resultsπ
#AnandRathi margin drops more than 1,000 points YoY
Board approves final dividend of βΉ7/sh
Board approves bonus issue in the ratio of 1:1
Net profit up 40.3% at βΉ103 cr vs βΉ73.7 cr (YoY)
Revenue up 29.6% at βΉ288 cr vs βΉ222 cr (YoY)
EBITDA down 6.7% at βΉ84.7 cr vs βΉ90.8 cr (YoY)
Margin at 29.4% vs 40.9% (YoY)
#AnandRathi margin drops more than 1,000 points YoY
Board approves final dividend of βΉ7/sh
Board approves bonus issue in the ratio of 1:1
Net profit up 40.3% at βΉ103 cr vs βΉ73.7 cr (YoY)
Revenue up 29.6% at βΉ288 cr vs βΉ222 cr (YoY)
EBITDA down 6.7% at βΉ84.7 cr vs βΉ90.8 cr (YoY)
Margin at 29.4% vs 40.9% (YoY)